In an era when public health challenges demand innovative solutions, a team led by Emma Welbourne has made a significant leap forward. With the support of government grants and leveraging open-source tools, their latest research, published under an open-access license, democratizes science by detailing a novel approach to mRNA sequence mapping. This method, crucial for the next generation of vaccines and gene therapies, underscores the value of public investment in science for the collective good.
Groundbreaking Publicly Funded Research Paves the Way for Advanced mRNA Therapies
Royal Society of Chemistry
Left Variant
Bias Score: 0.20
Read Original Article
Published: January 31, 2025
All Versions
Jan-31
Technology
Score: 0.50
Analyst, 2025, Accepted ManuscriptDOI: 10.1039/D5AN00033E, Paper Open Access   This article is licensed under a Creative Commons Attribution 3.0 Unported Licence.Emma Welbourne, Royce Copley, Gareth Owen, Caroline A. Evans, Kesler Isoko, Ken Cook, Joan Co…
From Royal Society of Chemistry
Jan-31
Technology
Right Variant
Score: 0.80
In a landmark study led by industry veteran Emma Welbourne and her team, including private sector talents like Ken Cook, a new method for mRNA sequence mapping has been unveiled, demonstrating the superiority of private innovation in the scientific realm. Funded in part by private investments and published under a Creative Commons license, this research not only highlights the inefficiencies of public funding but firmly establishes the pivotal role of free-market principles in driving medical breakthroughs.
From Royal Society of Chemistry